午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

GL Biochem (Shanghai) Ltd

Firmenname:GL Biochem (Shanghai) Ltd
Telefon:21-61263452
E-Mail:ymbetter@glbiochem.com
Nationalit?t:China
URL: www.glschina.com/
Produkte insgesamt:9981
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

Produktkatalog

β-Endorphin, equine
β-Secretase Substrate I, Fluorogenic
δ1-MSH, amide72629-65-3C72H97N21O14S
γ-2-MSH (41-58), amide;YVMGHFRWDRFG-NH2799841-81-9C74H100N22O15S
γ3-MSH:GAMMA3-MSH72629-64-2C126H188N44O37S
γ-Endorphin60893-02-9C83H131N19O27S
γ-MSH (3-8)98640-70-1C39H52N12O7S
γ-TAC4 (30-61)-NH2??;TEAETWEGAGPSIQLQLQEVKTGKASQFFGLM-NH2
δ-Endorphin (bovine, camel, mouse, ovine)66954-40-3C136H215N35O39S
δ-Endorphin (human)76622-84-9C139H217N33O40S
BREMELANOTIDE189691-06-3C50H68N14O10
Cetrorelix Acid;120287-85-6C70H92ClN17O14
Ganirelix Acetate123246-29-7C80H113ClN18O13
(Arg)9, FAM-labeled;FAM-RRRRRRRRRC75H120N36O16
(Arg)9, TAMRA-labeled;TAMRA-RRRRRRRRRC83H134ClN39O16
(pS8, pS13) Eucariotic Translation Initiation Factor 2B, eIF2B??;RRAAEELDpSRAGpSPQL
(Z-AR)2Rh110?2HCl;(Z-AR)2Rh110?HClC54H63Cl3N12O11
(Z-Arg)2Rh110 ? 2HCl;(Z-R)2Rh110?2HClC48H53Cl3N10O9
(Z-Phe-Arg)2Rh110;(Z-FR)2Rh110C66H69ClN12O11
?-Bag Cell Peptide;RLRFHC33H53N13O6
?-Neuroprotectin;aDLIAYL-NH2C37H60N8O10
[3,4-Dehydro-Pro]3-Thyrotropin Releasing Hormone, [ΔPro3]-TRH
[4-Chloro-Phe]7,8-Substance P;RPKPQQ-F(4-Cl-F)-GLM-NH273646-81-8C63H96Cl2N18O13S
[Ala144]-PLP (139-151) A144-PLP(139-151);HSLGKALGHPDKFC64H99N19O17
[Ala26, Leu27]-Melan-A (26-35);ALAGIGILTVC43H78N10O12
[Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTVC40H72N10O12
[Ala6,D-Trp8]-Galanin (1-15)-ol;GWTLNAAwYLLGPHA-olC81H114N20O18
[Cys3,6, Tyr8, Pro9]-Substance P;RPCPQCFYPLM-NH2(Disulfidebridge:3-6)141459-28-1C61H90N16O13S3
[D-Arg25]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALrHYINLITRQRY-NH2
[Deamino-Cys1, D-Arg8]-Vasopressin, free acid;3-Mercaptopropionyl-YFQNCPrG(Disulfidebridge:1-6)
[Des-Ac]-α-MSH, amide;SYSMEHFRWGKPV-NH2
[Des-Arg10]-HOE I40;rRP-Hyp-G-Thi-S-(D-Tic)-OicC53H77N15O12S
[D-His26]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRhYINLITRQRY-NH2
[D-Trp34]-Neuropeptide Y, human;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRwRY-NH2
[D-Trp6,8,9]-Galanin (1-15)-ol;GWTLNwAwwLLGPHA-olC91H120N22O17
[D-Tyr11]-Neurotensin;Pyr-LYENKPRRPyIL39379-15-2C78H121N21O20
[D-Tyr6, ?-Ala11, ?-Phe13, Nle14]-Bombesin (1-14);Pyr-QRLGyQWAV-(?-A)-H-(?-F)-Nle-NH2
[D-Tyr6, ?-Ala11, Phe13, Nle14]-Bombesin (6-14);yQWAV-(?-A)-HF-Nle-NH2
[Gln11]-beta-Amyloid (1-40);DAEFRHDSGYQVHHQKLVFFAEDVGSNKGAIIGLMVGGVV106686-61-7C145H210N42O45
[Gln144]-PLP (139-151), Q144-PLP(139-151);HSLGKQLGHPDKFC66H102N20O18
[Gln22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV
[Gln22]-beta-Amyloid (6-40);HDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV
[Gly22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV
[Gly30, Cys31] β-Amyloid (13-31)??NEW;HHQKLVFFAEDVGSNKGGC
[Ile34] Beta-Amyloid (25-34);GSNKGAIIGI
[Leu144]-PLP (139-151), L144-PLP(139-151);HSLGKLLGHPDKFC67H105N19O17
[Leu27]-Melan-A, MART 1 (26-35);ELAGIGILTVC45H80N10O14
[Leu28]-Melan-A (27-35);ALGIGILTVC40H73N9O11
[Lys0]-γ-1-MSH (41-58), amide;KYVMGHFRWDRFG-NH2C80H112N24O16S
[Lys4]-Sarafotoxin 6c;CTCKDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11)C105H157N27O36S5
[Lys5, NMeLeu9, NIe10]-Neurokinin A (4-10);DKFVG-(NMeL)-NIe-NH2C39H64N8O10
[Nle35] beta-Amyloid (17-42);LVFFAEDVGSNKGAIIGL-Nle-VGGVVIAC120H196N28O33
[Nle35]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVV
[Nle35]-beta-Amyloid (1-42);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVVIA
[Nle35]-Beta-Amyloid (25-35);GSNKGAIIGL-Nle163265-32-5C46H83N13O14
[pS119] CREB327 (113-126), Biotinyl??;Biotin-ILSRRP(pS)YRKILND
[pSer5]-Kemptide, 5-TMR labeled;5-TMR-LRRA-pS-LGC57H82N15O16P
[pSer5]-Kemptide, Biotinylated, Amide;Biotin-LRRA-pS-LG-NH2C42H77N16O13PS
[pSer5]-Kemptide, Biotinylated-LC;Biotin-LC-LRRA-pS-LGC48H85N16O15PS
[pSer5]-Kemptide, HiLyte Fluor? 488 labeled;HiLyteFluor?488-LRRA-pS-LG
[Pyr11]-beta-Amyloid (11-40);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV192377-94-9C143H226N38O39S
[Pyr11]-beta-Amyloid (11-42);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIAC152H242N40O41S
[Pyr3]-beta-Amyloid (3-40);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVC187H283N51O53S
[Pyr3]-beta-Amyloid (3-42);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA183449-57-2C196H299N53O55S1
[Ser102]-MCC (88-103), MCC (T102S);ANERADLIAYLKQASKC78H131N23O25
[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, human, rat;YSEEPPISLDLTFHLLREVLEEMARAEQLAQQAHSNRKLMEII-NH2100513-58-4C217H353N61O65S2
[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, ovine;YSQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2
[Tyr0]-α-Calcitonin Gene Related Peptide, [Tyr0]-α-CGRP, rat;YSCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7)
[Tyr11] Head Activator;Pyr-PPGGSKVILYC54H84N12O15
[Tyr22]-α-CGRP (22-37), rat;YVKDNFVPTNVGSEAF-NH2
[Tyr8]-Atrial Natriuretic Peptide (5-27), [Tyr8]-Atriopeptin II, rat;SSCYGGRIDRIGAQSGLGCNSFR(Disulfidebridge:3-19)C98H156N34O33S2
Beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL??;EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap(DABCYL)-OH
390 MMP FRET Substrate II;Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-OHC43H65N11O12
490 MMP FRET Substrate III;DABCYL-RPLALWRS-EDANSC73H100N20O13S
490 MMP FRET Substrate IV;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Asp(EDANS)-Ala-Arg-NH2C66H96N18O13S
490 MMP FRET Substrate V;NBD-RPKPLA-Nva-WK(DMC)-NH2C76H109N21O15
490 MMP FRET Substrate VI;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Dap(AMCA)-Ala-Arg-NH2C64H92N18O12
490 MMP FRET Substrate VII;Dabcyl-Lys-Pro-Leu-Ala-Nva-Dap(AMCA-X)-NH2C62H88N14O11
4A/4B Peptide (2);DEMEECASHLPY-K(Ac)-NH2C67H101N17O24S2
4A/4B Peptide (3), EDANS-labeled;DEMEECASHLPY-E(EDANS)-NH2C76H106N18O27S3
520 MMP FRET Substrate I;QXL520?-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate II;QXL?520-Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2C67H86N14O14
520 MMP FRET Substrate III;QXL?520-Pro-Leu-Gly-Cys(Me)-His-Ala-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate IV;5-FAM-Pro-Leu-Ala-Nva-Dap(QXL?520)-Ala-Arg-NH2
520 MMP FRET Substrate IX;QXL?520-RPLALWRK(5-FAM)-NH2
520 MMP FRET Substrate V;5-FAM-Pro-Leu-Gly-Leu-Dap(QXL?520)-Ala-Arg-NH2
520 MMP FRET Substrate VI;QXL?520-Pro-Leu-Gly-Met-Trp-Ser-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate VII;QXL?520-PYAYWMRK(5-FAM)-NH2
520 MMP FRET Substrate VIII;QXL?520-RPKPLA-Nva-WK(5-FAM)-NH2
520 MMP FRET Substrate X;QXL?520-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate XI;5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL?520)-NH2
520 MMP FRET Substrate XII;5-FAM-RPKPYA-Nva-WM-K(QXL?520)-NH2
520 MMP FRET Substrate XIII;5-FAM-RPKPVE-Nva-WRK(QXL?520)-NH2
520 MMP FRET Substrate XIV;QXL?520-γ-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2(Smc=S-Methyl-L-cysteine)
520 MMP FRET Substrate XV;QXL?520-γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2
520 MMP FRET Substrate XVI;QXL?520-RPKPQQFWK(5-FAM)-NH2
520 MMP FRET Substrate XVII;QXL?520-Lys-Pro-Leu-Ala-Nva-Dap(5-FAM)-Ala-Arg-NH2
580 MMP FRET Substrate I;QXL?570-Lys-Pro-Leu-Ala-Nva-Dap(5-TAMRA)-Ala-Arg-NH2
5A, pNA-labeled;EDVV-Abu-C-pNAC32H48N8O12S
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100
Copyright 2019 ? ChemicalBook. All rights reserved